How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?
The Turkish Journal of Gastroenterology · 2012
DOI: 10.4318/tjg.2012.0617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Turkish Journal of Gastroenterology, 2012. Verfasst von Gökhan Kabaçam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ankara University, School of Medicine, Ankara, Turkey. gokhankabacam@yahoo.com. Hauptthemen laut MEDLINE: Drug Resistance.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Ankara University, School of Medicine, Ankara, Turkey. gokhankabacam@yahoo.com
Zitieren
APA
Kabaçam, G., & Törüner, M. (2012). How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?. The Turkish Journal of Gastroenterology. https://doi.org/10.4318/tjg.2012.0617
Vancouver
Kabaçam G, Törüner M. How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?. The Turkish Journal of Gastroenterology. 2012. doi:10.4318/tjg.2012.0617
BibTeX
@article{Kabaam2012,
author = {Kabaçam, Gökhan and Törüner, Murat},
title = {How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?},
journal = {The Turkish Journal of Gastroenterology},
year = {2012},
doi = {10.4318/tjg.2012.0617}
}
EUVIMED